Xspray-logo-white
  • Home
  • About us
    • Business model
    • Our history – a timeline
    • Board of Directors & Board committees
    • Management
  • Technology
  • Pipeline
  • Media
  • Contact
  • Investors
  • en en
    • sv sv
  • Investors
    • Rights Issue 2023
    • Share information
      • Analysts
      • Trading information
      • Ownership structure
    • Financial calendar & Events
    • Financial reports
      • ESEF report
    • Prospectus
    • Press releases
    • Corporate governance
      • Corporate Structure
      • General meetings
      • Corporate Governance Reports
      • Nomination committee
      • Board of Directors & Board committees
      • Management
      • Accounting principles
      • Internal control & Risk management
      • Auditor
      • Articles of association
      • Remuneration

Press releases

All press releases Regulatory

Regulatory press release 2023-05-30

Xspray has published prospectus relating to its previously announced rights issue

Regulatory press release 2023-05-30

The Board of Directors of Xspray has resolved on a previously announced rights issue of units of approximately SEK 300 million ahead of Dasynoc product launch

Regulatory press release 2023-05-25

Bulletin from the extraordinary general meeting of Xspray Pharma AB (publ)

Regulatory press release 2023-05-16

Bulletin from the 2023 annual general meeting of Xspray Pharma AB (publ)

Regulatory press release 2023-05-04

Interim Report First Quarter 2023

Regulatory press release 2023-05-02

Notice of extraordinary general meeting in Xspray Pharma AB (publ)

Regulatory press release 2023-05-02

Xspray announces a rights issue of units of approximately SEK 300 million ahead of Dasynoc product launch

Press release 2023-04-26

Xspray Pharma receives expected partial decision in patent case regarding matter of law

Regulatory press release 2023-04-13

Notice of annual general meeting of Xspray Pharma AB (publ)

Regulatory press release 2023-03-29

Xspray Pharma publishes its Annual Report 2022

Show more

Subscribe

  • Submit to our press releases and get an email every time we publish a press release or report on our website.
  • When clicked on Send I agree that my personal information will be saved. Read more
  • This field is for validation purposes and should be left unchanged.

IR contact

Kerstin Hasselgren, Chief Financial Officer

+46 (0)70 311 16 83

info@xspray.com

Xspray-logo-white

Xspray Pharma AB Råsundavägen 12 169 67 Solna

+46 (0)8 730 37 00 info@xspraypharma.com